Objective: To characterize in vitro and in vivo binding, selectivity, and functional activity of CVL 354 a novel KOR antagonist.
Objective: To characterize in vitro and in vivo binding, selectivity, and functional activity of CVL 354 a novel KOR antagonist.
You are now leaving cerevel.com, a website provided by Cerevel Therapeutics. The content displayed on external websites is not controlled by Cerevel, and Cerevel assumes no responsibility for the information or statements on external websites.